Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 137 entries
View as:

Performance Study of Targeted Sequencing Technology for VAP

Phase: N/A Priority: Normal
NCT ID: NCT06035796 Org: User:
Start: 10/01/23 End: 10/30/25 Due: 10/30/26

The Preventive Effect of Different Doses of Intranasal Insulin on Postoperative Delirium

Phase: N/A Priority: Normal
NCT ID: NCT06443957 Org: User:
Start: 07/29/23 End: 04/13/24 Due: 04/13/25

Natural Killer(NK) Cell Combined With Programmed Death-1(PD-1) Antibody as Second Line Therapy for Advanced Driver Mutation Negative Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03958097 Org: User:
Start: 05/17/19 End: 10/21/21 Due: 10/21/22

Prospective Registration Study of Totally Laparoscopy Versus Laparoscopy Assisted Colon Cancer Surgery

Phase: N/A Priority: Normal
NCT ID: NCT04853784 Org: User:
Start: 05/01/21 End: 05/30/23 Due: 05/30/24

Mecapegfilgrastim(PEG-G-CSF) for Prophylaxis of Chemotherapy-induced Neutropenia in Patients With Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT04460508 Org: User:
Start: 12/20/20 End: 03/20/23 Due: 03/20/24

Daphnetin Capsules for Lower Limb Lymphoedema Following Gynaecological Surgery

Phase: N/A Priority: Normal
NCT ID: NCT06329167 Org: User:
Start: 03/25/24 End: 07/31/25 Due: 07/31/26

Detection of Minimal Residual Disease in Resectable Stage II-IIIB Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06267144 Org: User:
Start: 01/20/24 End: 12/17/25 Due: 12/17/26

Cardenilimab Combined With Lenvatinib in Patients With Perioperative Resectable Clear Cell Renal Cell Carcinoma.

Phase: N/A Priority: Normal
NCT ID: NCT06574412 Org: User:
Start: 09/01/24 End: 09/01/27 Due: 09/01/28

A Perspective Study of the Antiviral Efficacy and Safety of Switching to TAF Treatment in CHB Adults With Suboptimal Response (SOR) and Intolerant to Entecavir

Phase: N/A Priority: Normal
NCT ID: NCT04034368 Org: User:
Start: 08/31/19 End: 06/30/21 Due: 06/30/22

Effectiveness and Safety of Using Prontosan to Treat Bacterial Biofilm

Phase: N/A Priority: Normal
NCT ID: NCT06185465 Org: User:
Start: 01/03/24 End: 02/28/25 Due: 02/28/26

Preliminary Study of CXCL3 As a Biomarker of Diabetic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT06639529 Org: User:
Start: 06/10/24 End: 07/30/24 Due: 07/30/25

Clinical Study on the Accuracy of Real-time AI-assisted Endocytoscopy in the Diagnosis of Colorectal Diminutive Polyps

Phase: N/A Priority: Normal
NCT ID: NCT06791408 Org: User:
Start: 02/05/25 End: 12/31/25 Due: 12/31/26

To Explore the Feasibility of Dynamic Changes of TCR Diversity in Peripheral Blood in Monitoring Recurrence and Evaluating Prognosis of Epithelial Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06315270 Org: User:
Start: 03/20/24 End: 03/20/29 Due: 03/20/30

Ultrasonography of Optic Nerve Sheath Diameter for Noninvasive Detection of Raised Intracranial Pressure: ORIENT Study

Phase: N/A Priority: Normal
NCT ID: NCT04981548 Org: User:
Start: 11/06/21 End: 11/30/23 Due: 11/30/24

Total Neoadjuvant Chemoradiotherapy Plus Anti-PD-1 in Subperitoneal Patients With Locally Advanced Rectal CancerPatients With Locally Advanced Rectal Cancer: A Prospective, Single Arm, Exploratory Study

Phase: N/A Priority: Normal
NCT ID: NCT05998122 Org: User:
Start: 09/01/23 End: 12/31/28 Due: 12/31/29

Intrathecal Pemetrexed for Recurrent Leptomeningeal Metastases From Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03101579 Org: User:
Start: 03/01/17 End: 01/05/19 Due: 01/05/20

Pre-rehabilitation in Neoadjuvant Patients With Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05445401 Org: User:
Start: 08/01/22 End: 06/30/26 Due: 06/30/27

Randomized Controlled Clinical Study of Efficacy and Safety of Initumab Combined with Pyrrotinib and Chemotherapeutic Agents in Neoadjuvant Therapy for HER2-positive Breast Cancer with Different Treatment Cycles

Phase: N/A Priority: Normal
NCT ID: NCT06868017 Org: User:
Start: 04/01/25 End: 02/19/27 Due: 02/19/28

Factors Contribute to Very Late Stent Thrombosis After New Generation DES Implantation in China

Phase: N/A Priority: Normal
NCT ID: NCT03491891 Org: User:
Start: 01/01/14 End: 06/01/19 Due: 06/01/20

Apatinib Combined With Chemotherapy for NSCLC Patients Without T790M Mutation

Phase: N/A Priority: Normal
NCT ID: NCT03758677 Org: User:
Start: 08/01/20 End: 11/20/21 Due: 11/20/22

Radial Extracorporeal Shock Wave Therapy for Spastic Plantar Flexor Muscles in Young Children With Cerebral Palsy

Phase: N/A Priority: Normal
NCT ID: NCT02719483 Org: User:
Start: 04/30/14 End: 03/31/16 Due: 03/31/17

Reducing Postoperative Side Effect of Pregabalin

Phase: N/A Priority: Normal
NCT ID: NCT04599894 Org: User:
Start: 11/01/20 End: 05/04/21 Due: 05/04/22

Research on the Effect and Mechanism of Aerobic Exercise on PD

Phase: N/A Priority: Normal
NCT ID: NCT04651140 Org: User:
Start: 10/13/20 End: 10/30/21 Due: 10/30/22

A Clinical Study on the Efficacy and Safety of Fruquintinib in Combination With PD-1 Monoclonal Antibody and Chidamide in Refractory MSS Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06979908 Org: User:
Start: 01/22/25 End: 01/22/27 Due: 01/22/28

Anlotinib Single Drug as the Maintenance Treatment for Advanced NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT03998085 Org: User:
Start: 03/05/19 End: 12/31/21 Due: 12/31/22